Figure 2.
Overall survival of 2:1 case-matched cohort (age ± 5 years, sex, PS and duration on pembrolizumab ± 2 months) for Q3W and Q6W schedule (n = 113).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.